WD Lab Grown Diamonds has received an equity investment from Huron Capital Partners, LLC
WD Lab Grown Diamonds (WD) has received an equity investment from Huron Capital Partners LLC.
Founded in 2008, WD is a disruptive, rapidly growing producer of large, ultra-high-quality laboratory-grown diamonds for the jewelry, scientific and industrial markets. WD leverages patented and proprietary processes to grow diamonds with the same optical, chemical and physical properties as mined diamonds. The company’s exclusive technology and manufacturing capabilities place WD at the forefront of one of the fastest growing segments of the diamond industry. The company also offers new technologies and applications for diamonds in various other fields, including high pressure environments and medical and scientific uses. It partners with diamond retailers, wholesalers and manufacturers.
Huron Capital, a Detroit-based private equity firm with over US$1.8 billion of capital under management, expects to strategically accelerate WD’s future growth and further entrench its position as the world’s preeminent producer of gem-quality laboratory-grown diamonds.
This transaction provides resources and balance sheet flexibility to further accelerate WD’s impressive growth trajectory as well as a strategic partner for the company’s founding shareholders, who remain in day-to-day operational control.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to WD Lab Grown Diamonds in this transaction.


Talk to the deal team

James S. Grien
Managing Director
Atlanta, United StatesOaklins TM Capital


Related deals
OFFIX Holding and Office World Holding bundled their activities into the newly formed JV Office World Group
OFFIX Holding AG and Office World Holding AG have bundled their businesses into the newly founded Office World Group AG. Office World Holding brings its subsidiaries Office World, iba and Tramondi, and OFFIX brings its companies Papedis, Ecomedia, Oridis, Office Leader and DocuServ into the new Office World Group AG. The merger creates a Swiss group that will be represented throughout the country, generating sales of approximately US$400 million with just under 600 employees.
Learn moreAce Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Learn moreArgon Corporation has been acquired by Spectra
The private shareholders of Argon Corporation have sold the company to Spectra Aerospace and Defense, LLC (Spectra), a platform formed by Vance Street Capital.
Learn more